Bio-Techne (TECH) Share-based Compensation (2009 - 2026)
Bio-Techne's quarterly Share-based Compensation came in at $11.0 million in Q1 2026, up 2642.0% year-on-year from $400000.0 in Q1 2025, and up 2093.6% quarter-over-quarter from $500000.0 in Q4 2025.
Bio-Techne has reported Share-based Compensation for 18 years, with the latest figure at $11.0 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation rose 2642.0% year-over-year to $11.0 million; the trailing twelve-month figure through Mar 2026 stood at $27.7 million (down 15.77% YoY), and the FY2025 full-year result was $40.8 million, up 7.34% from the prior year.
- Share-based Compensation for Q1 2026 stood at $11.0 million, up from $500000.0 in the prior quarter.
- The five-year high for Share-based Compensation was $16.2 million in Q4 2022, with the low at -$2.1 million in Q2 2023.
- Average Share-based Compensation over 5 years is $7.4 million, with a median of $8.4 million recorded in 2022.
- Year-over-year, Share-based Compensation plunged 124.8% in 2023 and surged 4979.33% in 2024.
- Tracing TECH's Share-based Compensation over 5 years: stood at $16.2 million in 2022, then slumped by 98.15% to $300000.0 in 2023, then surged by 4979.33% to $15.2 million in 2024, then tumbled by 96.72% to $500000.0 in 2025, then soared by 2093.6% to $11.0 million in 2026.
- The last three Share-based Compensation figures came in at $11.0 million (Q1 2026), $500000.0 (Q4 2025), and $11.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 892,057.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 305,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 166.40 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 257.40 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 70.15 Mn |
| 10 | Bio-Techne | 7.92 Bn | 7.71 Bn | 208.29 Mn | 10.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 10.97 Mn |
| Mar 31, 2026 | 10.97 Mn |
| Dec 31, 2025 | 500,000.00 |
| Dec 31, 2025 | 500,000.00 |
| Sep 30, 2025 | 11.68 Mn |
| Sep 30, 2025 | 11.68 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Jun 30, 2025 | 4.55 Mn |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 15.24 Mn |
| Dec 31, 2024 | 15.24 Mn |
| Sep 30, 2024 | 10.18 Mn |
| Sep 30, 2024 | 10.18 Mn |
| Jun 30, 2024 | 7.06 Mn |
| Jun 30, 2024 | 7.06 Mn |
| Mar 31, 2024 | 8.10 Mn |
| Mar 31, 2024 | 8.10 Mn |
| Dec 31, 2023 | 300,000.00 |
| Dec 31, 2023 | 300,000.00 |
| Sep 30, 2023 | 10.09 Mn |
| Sep 30, 2023 | 10.09 Mn |
| Jun 30, 2023 | -2.09 Mn |
| Jun 30, 2023 | -2.09 Mn |
| Mar 31, 2023 | 200,000.00 |
| Mar 31, 2023 | 200,000.00 |
| Dec 31, 2022 | 16.20 Mn |
| Dec 31, 2022 | 16.20 Mn |
| Sep 30, 2022 | 14.46 Mn |
| Sep 30, 2022 | 14.46 Mn |
| Jun 30, 2022 | 8.41 Mn |
| Jun 30, 2022 | 8.41 Mn |
| Mar 31, 2022 | 9.06 Mn |
| Mar 31, 2022 | 9.06 Mn |
| Dec 31, 2021 | 400,000.00 |
| Dec 31, 2021 | 400,000.00 |
| Sep 30, 2021 | 11.74 Mn |
| Sep 30, 2021 | 11.74 Mn |
| Jun 30, 2021 | 12.67 Mn |
| Jun 30, 2021 | 12.67 Mn |
| Mar 31, 2021 | 400,000.00 |
| Mar 31, 2021 | 400,000.00 |
| Dec 31, 2020 | 15.60 Mn |
| Dec 31, 2020 | 15.60 Mn |
| Sep 30, 2020 | 12.95 Mn |
| Sep 30, 2020 | 12.95 Mn |
| Jun 30, 2020 | 6.02 Mn |
| Jun 30, 2020 | 6.02 Mn |
| Mar 31, 2020 | 8.09 Mn |
| Mar 31, 2020 | 8.09 Mn |
| Dec 31, 2019 | 10.62 Mn |
| Dec 31, 2019 | 10.62 Mn |
| Sep 30, 2019 | 8.80 Mn |
| Sep 30, 2019 | 8.80 Mn |
| Jun 30, 2019 | 8.13 Mn |
| Jun 30, 2019 | 8.13 Mn |
| Mar 31, 2019 | 5.73 Mn |
| Mar 31, 2019 | 5.73 Mn |
| Dec 31, 2018 | 6.90 Mn |
| Dec 31, 2018 | 6.90 Mn |
| Sep 30, 2018 | 11.57 Mn |
| Sep 30, 2018 | 11.57 Mn |
| Jun 30, 2018 | 14.65 Mn |
| Jun 30, 2018 | 14.65 Mn |
| Mar 31, 2018 | 4.70 Mn |
| Mar 31, 2018 | 4.70 Mn |
| Dec 31, 2017 | 5.00 Mn |
| Dec 31, 2017 | 5.00 Mn |
| Sep 30, 2017 | 3.80 Mn |
| Sep 30, 2017 | 3.80 Mn |
| Jun 30, 2017 | 3.41 Mn |
| Jun 30, 2017 | 3.41 Mn |
| Mar 31, 2017 | 3.97 Mn |
| Mar 31, 2017 | 3.97 Mn |
| Dec 31, 2016 | 4.10 Mn |
| Dec 31, 2016 | 4.10 Mn |
| Sep 30, 2016 | 3.19 Mn |
| Sep 30, 2016 | 3.19 Mn |
| Jun 30, 2016 | 2.75 Mn |
| Jun 30, 2016 | 2.75 Mn |
| Mar 31, 2016 | 2.32 Mn |
| Mar 31, 2016 | 2.32 Mn |
| Dec 31, 2015 | 2.32 Mn |
| Dec 31, 2015 | 2.32 Mn |
| Sep 30, 2015 | 2.04 Mn |
| Sep 30, 2015 | 2.04 Mn |
| Jun 30, 2015 | 1.23 Mn |
| Jun 30, 2015 | 1.23 Mn |
| Mar 31, 2015 | 1.29 Mn |
| Mar 31, 2015 | 1.29 Mn |
| Dec 31, 2014 | 2.08 Mn |
| Dec 31, 2014 | 2.08 Mn |
| Sep 30, 2014 | 1.36 Mn |
| Sep 30, 2014 | 1.36 Mn |
| Jun 30, 2014 | 888,000.00 |
| Jun 30, 2014 | 888,000.00 |
| Mar 31, 2014 | 700,000.00 |
| Mar 31, 2014 | 700,000.00 |
| Dec 31, 2013 | 1.30 Mn |
| Dec 31, 2013 | 1.30 Mn |
| Sep 30, 2013 | 569,000.00 |
| Sep 30, 2013 | 569,000.00 |
| Jun 30, 2013 | 490,000.00 |
| Jun 30, 2013 | 490,000.00 |
| Mar 31, 2013 | 286,000.00 |
| Mar 31, 2013 | 286,000.00 |
| Dec 31, 2012 | 785,000.00 |
| Dec 31, 2012 | 785,000.00 |
| Sep 30, 2012 | 303,000.00 |
| Sep 30, 2012 | 303,000.00 |
| Jun 30, 2012 | 252,000.00 |
| Jun 30, 2012 | 252,000.00 |
| Mar 31, 2012 | 241,000.00 |
| Mar 31, 2012 | 241,000.00 |
| Dec 31, 2011 | 858,000.00 |
| Dec 31, 2011 | 858,000.00 |
| Sep 30, 2011 | 290,000.00 |
| Sep 30, 2011 | 290,000.00 |
| Jun 30, 2011 | 201,000.00 |
| Jun 30, 2011 | 201,000.00 |
| Mar 31, 2011 | 87,000.00 |
| Mar 31, 2011 | 87,000.00 |
| Dec 31, 2010 | 714,000.00 |
| Dec 31, 2010 | 714,000.00 |
| Sep 30, 2010 | 136,000.00 |
| Sep 30, 2010 | 136,000.00 |
| Jun 30, 2010 | 175,000.00 |
| Jun 30, 2010 | 175,000.00 |
| Mar 31, 2010 | 81,000.00 |
| Mar 31, 2010 | 81,000.00 |
| Dec 31, 2009 | 777,000.00 |
| Dec 31, 2009 | 777,000.00 |
| Sep 30, 2009 | 102,000.00 |
| Sep 30, 2009 | 102,000.00 |